Skip to main content
SpringerLink
Log in

Lésions anopérinéales fistuleuses de la maladie de Crohn: l'anti-TNF alpha doit-il modifier nos attitudes thérapeutiques?

  • Ateliers
  • Published:
Acta Endoscopica

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. BRANDT L.J., BERNSTEIN L.H., BOLEY S.J., FRANK M.S. — Metronidazole therapy for perineal Crohn's disease: a follow-up study.Gastroenterology, 1982,83, 383–387.

    PubMed  CAS  Google Scholar 

  2. KORELITZ B.I., PRESENT D.H. — Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease.Dig. Dis. Sci., 1985,30, 58–64.

    Article  PubMed  CAS  Google Scholar 

  3. KORELITZ B.I., ADLER D.J., MENDELSON R.A., SCAKNOFF a.L. — Long term experience with 6-mercaptopurine in the treatment of Crohn's disease.Am. J. Gastroenterol., 1993,88, 1198–1205.

    PubMed  CAS  Google Scholar 

  4. McKEE R.F., KEENAN R.A. — Perianal Crohn's disease: is it all bad news?Dis. colon. rectum., 1996,39, 136–142.

    Article  PubMed  CAS  Google Scholar 

  5. EAGAN L.J., SANDBORN W.J., TREMAINE W.J. — Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.Am. J. Gastroenterol., 1998,93, 442–448.

    Article  Google Scholar 

  6. EHRENPREIS E.D., KANE S.V., COHEN L.B., COHEN R.D., HANAUER S.B. — Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.Gastroenterology, 1999,117, 1271–1277.

    Article  PubMed  CAS  Google Scholar 

  7. PRESENT D.H., RUTGEERTS P.J., TARGAN S.R., HANAUER S.B., MAYER L., VAN HOGEZAND R.A., PODOLSKY D.K., SANDS B.E., BRAAKMAN T., DEWOODY K.L., SCHAIBLE T.F., VAN DEVENTER S.J.H. — Infliximab for the treatment of fistulas in patients with Crohn's disease.N. Engl. J. Med., 1999,340, 1398–1405.

    Article  PubMed  CAS  Google Scholar 

  8. PRESENT D.H., LICHTIGER S. — Efficacy of cyclosporine in treatment of fistula of Crohn's disease.Dig. Dis. Sci., 1994,39, 374–380.

    Article  PubMed  CAS  Google Scholar 

  9. TARGAN S.R., HANAUER S.B., VAN DEVENTER S.J.H., MAYER L., PRESENT D.H., BRAAKMAN T., DEWOODY K.L., SCHAIBLE T.F., RUTGEERTS P.J. — A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.New. Engl. J. Med., 1997,337, 1029–1035.

    Article  PubMed  CAS  Google Scholar 

  10. D'HAENS G.R., VAN DEVENTER S.J.H., VAN HOGEZAND R.A., CHALMERS D., KOTHE C., BAERTS F., BRAAKMAN T., SCHAIBLE T.F., GEBOES K., RUTGEERTS P.J. — Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a european multicenter trial.Gastroenterology, 1999,116, 1029–1034.

    Article  PubMed  Google Scholar 

  11. VAN DULLERMAN H.M. — Treatment of therapy-resistant perineal metastatic Crohn's disease after protectomy using anti-tumor necrosis factor chimeric monoclonal anti-body, CA2. Report of two cases.Dis. colon. rectum, 1998,41, 98–102.

    Article  Google Scholar 

  12. D'HAENS G.R., AERDEN I., VAN HOGEZAND R.A., WESDORP C., KISIEL J., VAN DEVENTER S.J.H.et al. — Duration of response following cessation of infliximab therapy for active or fistulizing Crohn's disease.Gastroenterology, 1999,116, G3029.

    Google Scholar 

  13. BICKSTON S.J., LICHTENSTEIN G.R., ARSENEAU K.O., COHEN R.B., COMINELLI F. — The relationship between infliximab treatment and lymphoma in Crohn's disease.Gastroenterology, 1999,117, 1433–1437.

    Article  PubMed  CAS  Google Scholar 

  14. RUTGEERTS P.J., D'HAENS G., TARGAN S.R., VASILIAUSKAS E., HANAUER S.B., PRESENT D.H., MAYER L., VAN HOGEZAND R.A., BRAAKMAN T., DEWOODY K.L., SCHAIBLE T.F., VAN DEVENTER S.J.H. — Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.Gastroenterology, 1999,117, 761–769.

    Article  PubMed  CAS  Google Scholar 

  15. HANAUER S.B., COHEN R.D., BECKER R.V., LARSON L.R., VREELAND M.G. — Advances in the management of Crohn's disease: Economic anf clinical potential of infliximab.Clin. Therapeutics, 1998,20, 1009–1028.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinique du Château, 34, quai de Tounis, 31000, Toulouse, France

    G. Staumont

Authors
  1. G. Staumont
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Staumont, G. Lésions anopérinéales fistuleuses de la maladie de Crohn: l'anti-TNF alpha doit-il modifier nos attitudes thérapeutiques?. Acta Endosc 30 (Suppl 2), 385–388 (2000). https://doi.org/10.1007/BF03017984

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03017984

Search

Navigation